YBX1 and Hepatic fibrosis: identified the small molecule HSc025 as a direct ligand of YBX1 able to disrupt the interaction with PABP, resulting in accelerated nuclear translocation of YBX1 with an improvement from liver injury and hepatic fibrosis in mice (Higashi et al., 2011).